The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

This study was designed to determine the effects of vandetanib, a small-molecule receptor tyrosine kinase inhibitor of vascular endothelial growth factor and epidermal growth factor receptor, on paclitaxel (PTX) tumor distribution and antitumor activity in xenograft models of human ovarian carcinoma...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Cesca, M, Frapolli, R, Berndt, A, Scarlato, V, Richter, P, Kosmehl, H, D'Incalci, M, Ryan, A, Giavazzi, R
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2009

Ижил төстэй зүйлс

Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts
-н: Edmond Auzenne, зэрэг
Хэвлэсэн: (2007-06-01)

Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
-н: Wachsberger, P, зэрэг
Хэвлэсэн: (2009)

Determination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imaging.
-н: Lavinia Morosi, зэрэг
Хэвлэсэн: (2013-01-01)

Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.
-н: Choi, S, зэрэг
Хэвлэсэн: (2008)

Modulation of gene expression associated with copy number variation identifies key regulatory programs in high-grade serous ovarian carcinoma
-н: Martina Vescio, зэрэг
Хэвлэсэн: (2023-07-01)

Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma
-н: Hideki Iwamoto, зэрэг
Хэвлэсэн: (2011-03-01)

Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
-н: Demuytere J, зэрэг
Хэвлэсэн: (2024-01-01)

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.
-н: Cervellini, I, зэрэг
Хэвлэсэн: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat.
-н: Tai, J, зэрэг
Хэвлэсэн: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat
-н: Tai, J, зэрэг
Хэвлэсэн: (2010)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
-н: Nils Degrauwe, зэрэг
Хэвлэсэн: (2012-06-01)

Selective use of vandetanib in the treatment of thyroid cancer
-н: Fallahi P, зэрэг
Хэвлэсэн: (2015-07-01)

Biophysical and computational characterization of vandetanib–lysozyme interaction
-н: Kabir, Md Zahirul, зэрэг
Хэвлэсэн: (2018)

Investigating the effect of vandetanib and celecoxib combination on angiogenesis
-н: Abdul Qadir, MPhil, зэрэг
Хэвлэсэн: (2023-10-01)

Dermoscopic findings of perifollicular pigmentation associated with vandetanib
-н: Jade Cury-Martins, зэрэг
Хэвлэсэн: (2018-10-01)

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
-н: Roberta Affatato, зэрэг
Хэвлэсэн: (2022-05-01)

A novel compound ARN-3236 inhibits salt-inducible kinase 2 and sensitizes ovarian cancer cell lines and xenografts to paclitaxel.
-н: Zhou, J, зэрэг
Хэвлэсэн: (2016)

Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model.
-н: Alferez, D, зэрэг
Хэвлэсэн: (2010)

Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC
-н: Heymach, J, зэрэг
Хэвлэсэн: (2008)

Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).
-н: Siemann, D, зэрэг
Хэвлэсэн: (2009)

Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts
-н: Francesca Ricci, зэрэг
Хэвлэсэн: (2017-05-01)

Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro
-н: Yuxin Shen, зэрэг
Хэвлэсэн: (2025-03-01)

Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
-н: Ai Matsui, зэрэг
Хэвлэсэн: (2022-01-01)

Driving p53 Response to Bax Activation Greatly Enhances Sensitivity to Taxol by Inducing Massive Apoptosis
-н: Paola De Feudis, зэрэг
Хэвлэсэн: (2000-05-01)

Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts
-н: Joseph J. Caumanns, зэрэг
Хэвлэсэн: (2025-02-01)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
-н: Fallahi P, зэрэг
Хэвлэсэн: (2019-08-01)

Nitric oxide synthase inhibition enhances the antitumor effect of radiation in the treatment of squamous carcinoma xenografts.
-н: Robert J G Cardnell, зэрэг
Хэвлэсэн: (2011-01-01)

N-Acetylcysteine Augments Surface Thiols and Differentially Modulates Cell Adhesion and Invasion in vitro and Metastatic Potential in vivo of B16F1 Melanoma
-н: T. Laragione, зэрэг
Хэвлэсэн: (2005-01-01)

Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis
-н: Busra Demirbag Gul, зэрэг
Хэвлэсэн: (2022-02-01)

Antitumor action of an aminochromene derivative on human - derived lung adenocarcinoma xenograft model
-н: E. A. Samishina, зэрэг
Хэвлэсэн: (2019-06-01)

Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply
-н: Jr, W, зэрэг
Хэвлэсэн: (2012)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
-н: Carlos M. Galmarini, зэрэг
Хэвлэсэн: (2014-01-01)

Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives
-н: Alberto Zambelli, зэрэг
Хэвлэсэн: (2023-01-01)

LAMININ-5. A POTENTIAL TOOL IN DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
-н: Hartwig Kosmehl, зэрэг
Хэвлэсэн: (2002-12-01)

Colony-stimulating factor-1 receptor inhibition combined with paclitaxel exerts effective antitumor effects in the treatment of ovarian cancer
-н: Meijia Yu, зэрэг
Хэвлэсэн: (2024-05-01)

Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts
-н: Kumar, K, зэрэг
Хэвлэсэн: (2013)

Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts.
-н: Kumar, K, зэрэг
Хэвлэсэн: (2013)

BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models
-н: Federica Guffanti, зэрэг
Хэвлэсэн: (2024-06-01)

Vandetanib as a prospective anti-inflammatory and anti-contractile agent in asthma
-н: Xiaoyue Zeng, зэрэг
Хэвлэсэн: (2024-05-01)

A secondary RET mutation in the activation loop conferring resistance to vandetanib
-н: Takashi Nakaoku, зэрэг
Хэвлэсэн: (2018-02-01)